Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: integrated analysis from the CANVAS Program and CREDENCE trial
Yi TW, Wong MMY, Neuen BL, et al.
Diabetes Obes Metab. Pub. online 27 Mar 2023.
Leggi